v3.26.1
Stock Award Plans and Stock-based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense

The Company recognized stock-based compensation expense related to the issuance of stock option awards and restricted stock units to employees, non-employees and directors in the statements of operations as follows:

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Cost of goods sold

 

$

174,334

 

 

$

28,005

 

 

$

221,447

 

 

$

69,723

 

Research and development

 

 

148,137

 

 

 

43,942

 

 

 

210,496

 

 

 

122,097

 

Selling, clinical, and marketing

 

 

244,588

 

 

 

101,657

 

 

 

357,081

 

 

 

193,149

 

General and administrative

 

 

475,606

 

 

 

221,285

 

 

 

850,889

 

 

 

550,124

 

Total

 

$

1,042,665

 

 

$

394,889

 

 

$

1,639,913

 

 

$

935,093